
Results
169
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
169 companies
Mayinglong Pharmaceutical Group
Market Cap: CN¥12.4b
Engages in the manufacturing and sale of Chinese and Western medicines primarily in China.
600993
CN¥29.19
7D
7.8%
1Y
8.8%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥8.1b
Engages in the pharmaceutical business in China.
000915
CN¥34.18
7D
2.4%
1Y
19.9%
Philogen
Market Cap: €978.4m
A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.
PHIL
€24.30
7D
1.3%
1Y
19.7%
Strides Pharma Science
Market Cap: ₹88.7b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹959.45
7D
12.6%
1Y
-37.9%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.5b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س125.80
7D
-8.3%
1Y
-3.7%
Beximco Pharmaceuticals
Market Cap: ৳48.8b
Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
BXPHARMA
৳109.50
7D
-6.3%
1Y
41.1%
Kaken Pharmaceutical
Market Cap: JP¥138.8b
Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.
4521
JP¥3,670.00
7D
0.4%
1Y
-5.6%
Shilpa Medicare
Market Cap: ₹70.1b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹369.75
7D
2.4%
1Y
-12.3%
OSE Immunotherapeutics
Market Cap: €122.6m
A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.
OSE
€5.47
7D
-7.4%
1Y
-44.9%
Zhejiang Tianyu Pharmaceutical
Market Cap: CN¥8.7b
Engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally.
300702
CN¥24.92
7D
-4.2%
1Y
43.3%
Zhejiang Medicine
Market Cap: CN¥13.7b
Manufactures and sells life nutrition and pharmaceutical products in China.
600216
CN¥14.63
7D
1.5%
1Y
-21.2%
Cronos Group
Market Cap: CA$1.3b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$3.47
7D
1.2%
1Y
20.5%
Takara Bio
Market Cap: JP¥110.1b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥907.00
7D
-1.7%
1Y
-8.7%
HitGen
Market Cap: CN¥9.6b
Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.
688222
CN¥23.71
7D
-4.4%
1Y
77.6%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.01
7D
-0.3%
1Y
77.0%
Genovis AB (publ.)
Market Cap: SEK 1.4b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 21.20
7D
-6.8%
1Y
5.7%
Dong-A Socio Holdings
Market Cap: ₩692.5b
Engages in the pharmaceutical business in South Korea.
A000640
₩109,100.00
7D
0.6%
1Y
-8.3%
Fine Foods & Pharmaceuticals N.T.M
Market Cap: €228.4m
Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
€9.34
7D
-0.4%
1Y
13.6%
Cosmo Pharmaceuticals
Market Cap: CHF 1.0b
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 64.30
7D
-4.3%
1Y
-0.5%
Qingdao Vland Biotech
Market Cap: CN¥3.9b
Engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally.
603739
CN¥15.74
7D
3.1%
1Y
3.8%
Gyre Therapeutics
Market Cap: US$658.5m
A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.
GYRE
US$7.39
7D
-2.0%
1Y
-52.8%
Newron Pharmaceuticals
Market Cap: CHF 284.6m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 14.26
7D
0%
1Y
84.7%
Faes Farma
Market Cap: €1.4b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.39
7D
-2.4%
1Y
24.9%
ChemoMetec
Market Cap: DKK 12.7b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 728.50
7D
-6.5%
1Y
95.2%
Akums Drugs and Pharmaceuticals
Market Cap: ₹72.1b
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.
AKUMS
₹460.35
7D
-1.4%
1Y
-42.6%